Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples. [electronic resource]
Producer: 20161223Description: 969-75 p. digitalISSN:- 1536-4844
- Adolescent
- Adult
- Aged
- Animals
- Antibodies, Monoclonal -- immunology
- Biological Assay -- methods
- Biosimilar Pharmaceuticals -- therapeutic use
- Colitis, Ulcerative -- blood
- Crohn Disease -- blood
- Dose-Response Relationship, Immunologic
- Enzyme-Linked Immunosorbent Assay -- methods
- Female
- Follow-Up Studies
- Gastrointestinal Agents -- therapeutic use
- Humans
- Infliximab -- therapeutic use
- Male
- Mice
- Middle Aged
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.